{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:32:26Z","timestamp":1791685946403,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ibroneuroreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IBRO Neuroscience Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ibneur.2026.01.001","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T23:32:54Z","timestamp":1767483174000},"page":"94-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Norepinephrine and dopamine Imbalance in the medial frontal gyrus from patients with Alzheimer's disease"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0353-2590","authenticated-orcid":false,"given":"Zuleyha Nihan","family":"Yurtsever","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7863-1801","authenticated-orcid":false,"given":"Silvia","family":"Capuani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Fratini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Nicaise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine","family":"Salman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Hanseeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Augusto","family":"Carlesimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele Claudio","family":"Latagliata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7059-7015","authenticated-orcid":false,"given":"Roberto","family":"Coccurello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ibneur.2026.01.001_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1155\/NP.2000.133","article-title":"Through the looking glass: differential noradenergic modulation of prefrontal cortical function","volume":"7","author":"Amsten","year":"2000","journal-title":"Neural Plast."},{"key":"10.1016\/j.ibneur.2026.01.001_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.pbb.2011.01.020","article-title":"Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit\/hyperactivity disorder and related disorders","volume":"99","author":"Arnsten","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ibneur.2026.01.001_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3233\/JAD-210191","article-title":"The locus coeruleus in aging and Alzheimer\u2019s disease: a postmortem and brain imaging review","volume":"83","author":"Beardmore","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ibneur.2026.01.001_bib4","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1126\/science.1100021","article-title":"Protein kinase C overactivity impairs prefrontal cortical regulation of working memory","volume":"306","author":"Birnbaum","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ibneur.2026.01.001_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3233\/JAD-200276","article-title":"Computational modeling of catecholamines dysfunction in Alzheimer\u2019s disease at pre-plaque stage","volume":"77","author":"Caligiore","year":"2020","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.ibneur.2026.01.001_bib6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuropharm.2004.09.005","article-title":"Different nicotinic acetylcholine receptor subtypes mediating striatal and prefrontal cortical [3H]dopamine release","volume":"48","author":"Cao","year":"2005","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.ibneur.2026.01.001_bib7","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3390\/antiox12040955","article-title":"Oxidative stress and neuroinflammation in parkinson\u2019s disease: the role of dopamine oxidation products","volume":"12","author":"Chakrabarti","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.ibneur.2026.01.001_bib8","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-025-01736-4","article-title":"Repetitive prefrontal tDCS activates VTA dopaminergic neurons, resulting in attenuation of Alzheimer\u2019s disease-like deficits in Tg2576 mice","volume":"17","author":"De Paolis","year":"2025","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.ibneur.2026.01.001_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2011.02.036","article-title":"The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit\/hyperactivity disorder","volume":"69","author":"Del Campo","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ibneur.2026.01.001_bib10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0304-3940(02)00307-5","article-title":"Increased monoamine oxidase messenger RNA expression levels in frontal cortex of Alzheimer\u2019s disease patients","volume":"326","author":"Emilsson","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ibneur.2026.01.001_bib11","article-title":"Impact of noradrenergic inhibition on neuroinflammation and pathophysiology in mouse models of Alzheimer\u2019s disease","author":"Evans","year":"2024","journal-title":"Res. Sq."},{"key":"10.1016\/j.ibneur.2026.01.001_bib12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41386-021-01132-0","article-title":"The role of prefrontal cortex in cognitive control and executive function","volume":"47","author":"Friedman","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ibneur.2026.01.001_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2015.00220","article-title":"Noradrenergic dysfunction in Alzheimer\u2019s disease","volume":"9","author":"Gannon","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ibneur.2026.01.001_bib14","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1523\/JNEUROSCI.20-03-01208.2000","article-title":"Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex","volume":"20","author":"Granon","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ibneur.2026.01.001_bib15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10863-009-9257-z","article-title":"The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson\u2019s disease","volume":"41","author":"Hastings","year":"2009","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.ibneur.2026.01.001_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6137521","article-title":"Oxidative stress and neuroinflammation potentiate each other to promote progression of dopamine neurodegeneration","volume":"2020","author":"He","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ibneur.2026.01.001_bib17","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers","author":"Jack","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.ibneur.2026.01.001_bib18","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/j.1471-4159.2010.06889.x","article-title":"Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice","volume":"114","author":"K\u00e4enm\u00e4ki","year":"2010","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.ibneur.2026.01.001_bib19","first-page":"1","article-title":"Locus coeruleus cellular and molecular pathology during the progression of Alzheimer\u2019s disease","volume":"51","author":"Kelly","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ibneur.2026.01.001_bib20","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00702-003-0828-6","article-title":"Early and persistent alterations in prefrontal cortex MAO A and B in Alzheimer\u2019s disease","volume":"110","author":"Kennedy","year":"2003","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ibneur.2026.01.001_bib21","doi-asserted-by":"crossref","DOI":"10.1046\/j.1471-4159.1994.62010282.x","article-title":"Postmortem stability of monoamines, their metabolites, and receptor binding in rat brain regibns","volume":"62","author":"Kontur","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ibneur.2026.01.001_bib22","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1093\/cercor\/bhw252","article-title":"Cortical control of striatal dopamine transmission via striatal cholinergic interneurons","volume":"26","author":"Kosillo","year":"2016","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.ibneur.2026.01.001_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2018.00254","article-title":"Noradrenergic hypothesis linking neurodegeneration-based cognitive decline and astroglia","volume":"11","author":"Leanza","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ibneur.2026.01.001_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3390\/metabo12020101","article-title":"TDP-43 proteinopathy causes broad metabolic alterations including TCA cycle intermediates and dopamine levels in Drosophila models of ALS","volume":"12","author":"Loganathan","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.ibneur.2026.01.001_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102578","article-title":"Non-canonical pathways associated to Amyloid beta and tau protein dyshomeostasis in Alzheimer\u2019s disease: a narrative review","volume":"102","author":"Maggiore","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"34","key":"10.1016\/j.ibneur.2026.01.001_bib26","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1038\/npp.2009.60","article-title":"Dopamine modulates cholinergic cortical excitability in Alzheimer\u2019s disease patients","volume":"3410","author":"Martorana","year":"2009","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.ibneur.2026.01.001_bib27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0306-4522(02)00556-0","article-title":"Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function","volume":"116","author":"Matsumoto","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.ibneur.2026.01.001_bib28","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/bpa.12424","article-title":"TDP-43 pathology in Alzheimer\u2019s disease, dementia with Lewy bodies and ageing","volume":"27","author":"McAleese","year":"2017","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ibneur.2026.01.001_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1478-811X-11-34","article-title":"Complexity of dopamine metabolism","volume":"11","author":"Meiser","year":"2013","journal-title":"Cell Commun. Signal."},{"issue":"16","key":"10.1016\/j.ibneur.2026.01.001_bib30","first-page":"1","article-title":"TDP-43 pathology in Alzheimer\u2019s disease","volume":"161","author":"Meneses","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ibneur.2026.01.001_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2990.2008.01003a.x","article-title":"PH measurement as quality control on human post mortem brain tissue: a study of the BrainNet Europe consortium","volume":"35","author":"Monoranu","year":"2009","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.ibneur.2026.01.001_bib32","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/brain\/awx327","article-title":"Neurotransmitter deficits from frontotemporal lobar degeneration","volume":"141","author":"Murley","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.ibneur.2026.01.001_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14727","article-title":"Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer\u2019s disease","volume":"8","author":"Nobili","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ibneur.2026.01.001_bib34","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3389\/fnagi.2020.00184","article-title":"Catecholamines in Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"12","author":"Pan","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ibneur.2026.01.001_bib35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fnagi.2019.00175","article-title":"Dopamine and dopamine receptors in Alzheimer\u2019s disease: a systematic review and network meta-analysis","volume":"10","author":"Pan","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ibneur.2026.01.001_bib36","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1093\/cercor\/bhm008","article-title":"The medial prefrontal cortex determines the accumbens dopamine response to stress through the opposing influences of norepinephrine and dopamine","volume":"17","author":"Pascucci","year":"2007","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.ibneur.2026.01.001_bib37","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/cne.24397","article-title":"Essential role of hippocampal noradrenaline in the regulation of spatial working memory and TDP-43 tissue pathology","volume":"526","author":"Pintus","year":"2018","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ibneur.2026.01.001_bib38","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.pharmthera.2006.11.006","article-title":"Adrenergic pharmacology and cognition: focus on the prefrontal cortex","volume":"113","author":"Ramos","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ibneur.2026.01.001_bib39","first-page":"1","article-title":"Monoamine alterations in Alzheimer\u2019s disease and their implications in comorbid neuropsychiatric symptoms","author":"Saggu","year":"2024","journal-title":"GeroScience"},{"key":"10.1016\/j.ibneur.2026.01.001_bib40","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.neuroscience.2007.01.031","article-title":"Changes in adrenoreceptors in the prefrontal cortex of subjects with dementia: evidence of compensatory changes","volume":"146","author":"Szot","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.ibneur.2026.01.001_bib41","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0022-3999(02)00428-2","article-title":"Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update","volume":"53","author":"Tekin","year":"2002","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.ibneur.2026.01.001_bib42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40478-015-0215-1","article-title":"Incidence and extent of TDP-43 accumulation in aging human brain","volume":"3","author":"Uchino","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ibneur.2026.01.001_bib43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neurobiolaging.2021.01.024","article-title":"Elevated norepinephrine metabolism is linked to cortical thickness in the context of Alzheimer\u2019s disease pathology","volume":"102","author":"van Hooren","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ibneur.2026.01.001_bib44","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1016\/j.neurobiolaging.2014.05.031","article-title":"Monoaminergic neurotransmitter alterations in postmortem brain regions of depressed and aggressive patients with Alzheimer\u2019s disease","volume":"35","author":"Vermeiren","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ibneur.2026.01.001_bib45","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0006-3223(01)01252-5","article-title":"Prefrontal neurons and the genetics of schizophrenia","volume":"50","author":"Weinberger","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ibneur.2026.01.001_bib46","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.4103\/NRR.NRR-D-24-00230","article-title":"The dopaminergic system and Alzheimer\u2019s disease","volume":"20","author":"Zhang","year":"2025","journal-title":"Neural Regen. Res."}],"container-title":["IBRO Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242126000011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242126000011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T20:13:44Z","timestamp":1782159224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667242126000011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":46,"alternative-id":["S2667242126000011"],"URL":"https:\/\/doi.org\/10.1016\/j.ibneur.2026.01.001","relation":{},"ISSN":["2667-2421"],"issn-type":[{"value":"2667-2421","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Norepinephrine and dopamine Imbalance in the medial frontal gyrus from patients with Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"IBRO Neuroscience Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ibneur.2026.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Brain Research Organization.","name":"copyright","label":"Copyright"}]}}